Pharmicell Co., Ltd. (KRX:005690)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,480
-200 (-1.58%)
At close: Jul 25, 2025, 3:30 PM KST

Pharmicell Revenue

Pharmicell had revenue of 3.65B KRW in the quarter ending June 30, 2014, a decrease of -58.16%. This brings the company's revenue in the last twelve months to 23.94B, down -3.60% year-over-year. In the year 2013, Pharmicell had annual revenue of 33.41B with 200.63% growth.

Revenue (ttm)
23.94B
Revenue Growth
-3.60%
P/S Ratio
31.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
748.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 201333.41B22.29B200.63%
Dec 31, 201211.11B829.38M8.07%
Dec 31, 201110.28B3.07B42.47%
Dec 31, 20107.22B28.94M0.40%
Dec 31, 20097.19B-1.14B-13.68%
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4,898.69B
Celltrion3,662.23B
ALTEOGEN151.65B
Yuhan2,114.76B
SK Biopharmaceuticals578.00B
Peptron4.30B
HLB Co., Ltd.74.64B
PharmaResearch392.31B
Revenue Rankings